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Objective: The purpose of this study was to evaluate and report our treatment policies in the management of nonpulmo-
nary arterial aneurysms in Behçet disease and to assess the prognosis in a cohort of 25 patients diagnosed between 1996
and 2007 by formally reassessing their outcome at the present time.
Methods: We identified 25 patients (24 men/1 woman) with Behçet disease with nonpulmonary aneurysms (n  23) or
occlusions (n  2) between 1996 and 2007. All patients fulfilled the International Study Group Criteria for Behçet
disease. Aneurysms were demonstrated with contrast-enhanced computed tomography (CT) or magnetic resonance
angiography (MRA) after first-line ultrasonography. Standard surgical procedures were carried out in 22 patients. One
patient with a nonruptured saccular aortic aneurysm and 2 patients with carotid aneurysms were managed only medically.
For the patients with aneurysms located in the aortic bifurcation, we preferred aorto-bi-iliac bypasses; for the six
extremity aneurysms, we were able to ligate the arteries; and for the other 10 extremity aneurysms we used polytetra-
fluoroethylene (PTFE) grafts for bypass procedures. All patients received immunosuppression with cyclophosphamide
and corticosteroids before the operation and were continued in the postoperative period. All patients were examined
between January and December 2010 paying special attention for new and anastomotic aneurysms and graft patency.
Results: There was one death and 1 patient was lost to follow-up. The remaining 23 patients (92%) were under follow-up
after a mean of 7.4  2.9 years after their operation. Four PTFE grafts (40%) inserted for extremity aneurysms occluded
with no disabling consequences. Also, 6 patients who were treated with ligation postoperatively began to complain of
mild to moderate claudication. In 2 patients, aneurysms recurred at the anastomotic site, whereas in 3 patients, new
aneurysms developed at other sites.
Conclusion: The surgical management of large, nonpulmonary arterial disease of Behçet disease is currently quite
satisfactory. When the false aneurysm is in the infrarenal aorta, aorto-bi-iliac bypass is the preferred surgical intervention.
Extremity aneurysms can be treated with synthetic graft insertion. In selected cases, ligation can give satisfactory results;
however, postoperative claudication is common. In some patients with small intact saccular aneurysms, surgery may not
be necessary. Patients must be prescribed immunosuppressive therapy with cyclophosphamide and corticosteroids before
and after the surgical intervention in order to avoid Behçet disease activation. (J Vasc Surg 2012;55:157-63.)
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pBehçet disease is a multisystem vasculitis characterized
mainly by skin mucosa lesions.1,2 It may also involve the
eyes, blood vessels of all size and types, the central nervous
system, and joints.2 Vascular disease develops in up to 25%
to 35% of the patients and has a definite male preponder-
ance.3,4 Venous involvement is more common than arterial
disease (75% vs 25%).2-4 The most common manifestation
is deep venous thrombosis (DVT) in a lower extremity,
followed frequently by vena cava disease, pulmonary artery
disease, aortic or peripheral artery aneurysms, venous sinus
thrombosis, and Budd-Chiari syndrome.4
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doi:10.1016/j.jvs.2011.07.049Large artery involvement is seen in 1.5% to 2.2% of all
atients with Behçet disease, whereas aneurysmal pathol-
gy is more common than occlusions.2,4,5 The most com-
on sites for aneurysm development are the abdominal
orta, pulmonary, femoral, popliteal, and carotid arter-
es.2,4,5 The main pathologic event is a lymphocytic and
eutrophilic necrotizing vasculitis leading to saccular aneu-
ysms and rupture.6 Immunosuppressive therapy with or
ithout vascular surgery is used in disease control.7 Recur-
ent aneurysm formation after open surgical and stent graft
reatment is a frequent and serious complication.8-10 Due
o its unique pathology, surgical as well as medical manage-
ent methods are different from atherosclerotic aneu-
ysms. As a dedicated Behçet disease vascular disease refer-
al center, herein we report our experience with 25 patients
ith Behçet disease referred to us within a decade with
mphasis on disease features, management, and prognosis.
ETHODS
From 1996 to 2007, 23 patients with Behçet disease
ith nonpulmonary artery aneurysms and 2 patients with
eripheral arterial occlusions had been treated at the De-
artment of Cardiovascular Surgery, Cerrahpasa Medical
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January 2012158 Tuzun et alFaculty, Istanbul, Turkey. Sixteen of these patients were
referred from the multidisciplinary Behçet disease outpa-
tient clinic of the same university hospital, while the re-
maining 9 patients were referred from other hospitals with
the diagnosis of Behçet disease and aneurysm formation.
The multidisciplinary Behçet disease outpatient clinic of
our hospital has been operative for over 30 years, the staff
meets weekly, currently has around 8000 registered pa-
tients, and regularly consults our surgical department for
any patient with large arterial disease.
All patients fulfilled the International Study Group
criteria11 for Behçet disease at the onset of arterial disease
and had been diagnosed as Behçet disease before referral,
except for 1 patient. This 37-year-old man was referred by
another hospital with a false aneurysm of the aorta. We first
suspected that the diagnosis was Behçet disease based on
the morphology of the aneurysm during the operation, and
then the diagnosis was verified by the Behçet disease re-
search center of our hospital. Arterial disease was diagnosed
either by Doppler scan, computed tomography (CT), or by
magnetic resonance angiography (MRA).
Medical therapy (cyclophosphamide and corticoste-
roids), as a rule, was initiated as soon as the patient was
hospitalized and prepared for surgery. Details will be given
further on in this study.
In this cohort, 22 of 25 patients were treated surgically,
whereas 3 patients (1 with an abdominal aorta and 2 with
carotid arteries) with small asymptomatic saccular aneu-
rysms received only medical treatment. In 1 among 22
operated cases, large ruptured saccular aneurysm was
treated operatively, whereas a small nonruptured saccular
aneurysm of the same aorta was followed under medical
therapy alone.
During the postoperative period, all patients were seen
every 3 to 6 months with routine physical examination,
including peripheral pulse examination and blood/urine
tests by the multidisciplinary Behçet disease outpatient
clinic. CT, MRA, or Doppler scan were obtained yearly.
Between January and December 2010, all patients were
called back to the outpatient clinic for formal evaluation to
investigate the long-term outcome, including Behçet dis-
ease activation, clinical status, graft patency, and new or
recurrent aneurysm formation. The outcome information
was taken with the help of a telephone interview in only 1
patient. This patient had attended our outpatient clinic for
1 year after his operation and is currently followed by
another center.
Statistical analysis. Continuous variables with a more
or less normal distribution were expressed as means  SDs
and others as medians and interquartile ranges. Statistical
analyses were carried out using statistical software (SPSS,
version 13.0 for Windows; SPSS, Chicago, Ill).
RESULTS
A total of 25 patients (24 man/1 woman) with Behçet
disease with nonpulmonary aneurysms and occlusions were
referred to our vascular surgery department between the
years 1996 and 2007. Demographic and clinical character- wstics are shown in Table I. The mean age at the diagnosis of
ascular lesions was 39  10 and the mean time elapsed
etween the diagnosis of Behçet disease and emergence of
ascular disease was 9.0  7.9 years. Venous thrombosis
as present in the majority of the patients (22 of 25; 88%),
ainly in the form of lower extremity DVT (17 of 25;
8%). Three of 25 patients (25%) had vena cava thrombo-
is. None of the patients had pulmonary artery involve-
ent. Nine patients (38%) had eye disease, of which 5
atients (20%) had loss of useful vision. Neurological dis-
ase was seen in 2 patients (8%): 1 patient had dural sinus
hrombi and the other had parenchymal central nervous
ystem disease.
Aneurysms or occlusions. As shown in Table II,
here were a total of 23 patients with 26 aneurysms and 2
atients with 2 occlusions. Three patients had a second new
neurysm in the popliteal artery - abdominal aorta (n 1);
opliteal artery - superficial femoral artery (n  1), and
osterior tibial artery - superficial femoral artery (n  1),
able I. Demographic and clinical characteristics of the
atients with Behçet disease with nonpulmonary artery
isease
n  25
en, n (%) 24 (96)
ge at aneurysm’s onset, mean  SD, years 39  10
isease duration, mean  SD, years 9.0  7.9
anifestation of Behçet disease, n (%)
Oral ulcers 25 (100)
Genital ulcers 18 (72)
Papulopustular lesions 14 (58)
Erythema nodosum 13 (54)
Venous thrombosis 22 (88)
Eye disease 9 (38)
Terminal eye disease 5 (20)
Neurological disease 2 (8)
igns and symptoms at presentation n (%)
Pulsatile mass 5 (20)
Painful mass 8 (32)
Back and or abdominal pain 7 (28)
Mass in the neck 3 (12)
Digital gangrene 1 (4)
Transient ischemic attack 1 (4)
able II. Anatomic localization of 26 aneurysms (initial
nd new) in 23 patients
Number
bdominal aortic 7
liac 1
ommon femoral 5
uperficial femoral 3
opliteal 5
arotid 3
osterior tibial 1
liofemoral saphenous graft 1hereas 2 patients had anastomotic aneurysms. The mean
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Volume 55, Number 1 Tuzun et al 159aneurysm diameter (taking the largest diameter) was 4.4
2.0 SD cm. Apart from the aneurysms, 1 patient was
operated on for superficial femoral artery occlusion that led
to digital gangrene and another for carotid artery stenosis at
the bifurcation level causing transient ischemic attacks. The
most common localization for arterial involvement was the
infrarenal abdominal aorta followed by the popliteal, com-
mon femoral, and carotid arteries.
Surgical procedures. Surgical procedures performed
are listed in Table III. We had performed almost the same
operations as in our first report8: “polytetrafluoroethylene
(PTFE) graft interposition” was done in 2 aortic, 1 iliac, 5
common femoral, 1 superficial femoral, 3 popliteal, and 1
common carotid artery aneurysms. We had done “aorto-bi-
iliac bypass (PTFE)” in 3 aortic aneurysms, and 1 patch
closure of the aortic defect above the superior mesenteric
artery. In infrarenal aortic aneurysms, we preferred to use
bifurcated grafts instead of tubular grafts. In this way,
we excluded the aorta and the bifurcation where recurrence
occurred frequently as had been brought up in our earlier
manuscript (2 of 9 abdominal aortic aneurysms).8 From
our earlier experience with 24 patients with Behçet disease,
we had learned that grafts inserted for extremity aneurysms
occluded without disabling ischemia.8 Based on this, we
were able to ligate two superficial femoral, two popliteal,
one posterior tibial arteries, and one venous conduit be-
tween external iliac and common femoral arteries. Apart
from these, we had 1 patient with digital gangrene who
required femoro below-knee bypass for occlusion. Also, in
another young patient with transient ischemic attacks, in-
ternal carotid artery stenosis was treated by endarterectomy
and PTFE patching.
Among the patients referred to us, we had operated on
all aneurysms except for 3 patients with asymptomatic
intact aneurysms. In 1 patient, there were three saccular
aneurysms at the aorta (1 cm each; Fig 1). In another
patient, there was a 2-cm saccular aneurysm at carotid
bifurcation. The remaining patient had presented with
bilateral fusiform aneurysms at the common carotid arteries
(3 and 2 cm; Fig 2). Among the patients we operated on,
Table III. Types of surgical procedures
Number
Aneurysmorrhaphy (patching) 1
Aortic tube graft interpositiona 3
Iliac artery tube graft interpositiona 1
Aorto-bi-iliac bypassa 3
Common femoral graft interpositiona 5
SFA graft interpositiona 1
Femoropopliteal bypassa 1
Popliteal graft interpositiona 3
Carotid graft interpositiona 1
Ligation 6
Carotid endarterectomy 1
SFA, Superficial femoral artery.
aPolytetrafluoroethylene (PTFE) graft.there was 1 patient whose symptomatic bifurcation aneu- cysm (7.5 cm) was treated with a bypass procedure, whereas
he nonruptured aneurysm at the level of superior mesen-
eric artery (1.5) was given only medical treatment.
Pathology. The main macroscopic pathology in all
atients was either intact or ruptured but contained saccu-
ar pseudoaneurysms. They were found to be surrounded
y a thick fibrotic tissue and enlarged lymph glands. Patho-
ogic investigation was available in almost all patients and
evealed similar findings to that found in our previous
eport.8 Briefly, this was characterized as infiltration of
nflammatory cells, especially around the vasa vasorum,
isruption of internal elastic membrane, loss of elastic and
uscle fibers in the media, periadventitial, and intimal
brosis along with organized thrombi (Fig 3). In the
urrent group, there was only 1 patient in whom athero-
clerotic changes were more prominent than inflammatory
asculitis.
New aneurysms/recurrences. Three patients had
ew aneurysms at previously uninvolved sites and 2 patients
ad recurrences. All patients were under immunosuppres-
ive treatment.
One patient who underwent a PTFE interposition for
opliteal artery aneurysm, developed a second aneurysm
his time in the abdominal aorta 2 years after the first
resentation. Aneurysm at the abdominal aorta was treated
ith aorto-bi-iliac bypass. In another patient whose popliteal
rtery aneurysm was treated with a PTFE graft interposition
hich occluded 3 months later, a superficial femoral artery
neurysm developed after 2 years. This aneurysm was ligated.
n another patient whose posterior tibial artery was ligated,
eveloped a superficial femoral artery aneurysm which was
reated with PTFE interposition.
Recurrence at the initial surgical site occurred in 2
atients. One patient had anastomotic dehiscence which
ccurred at the aortic patch 6 months after the surgery.
his patient died of exsanguination while waiting for an
ndograft. The other patient had a false aneurysm at the
TFE femoral artery anastomosis. He was treated with
igation. Apart from these, there were no other recurrences
r new aneurysm formation.
Graft occlusion. Four extremity grafts of 10 (40%)
ere occluded. One common and one superficial femoral
rtery graft occluded at 1 year, one popliteal artery graft
ccluded 3 months later, and another popliteal artery graft
ccluded shortly after operation with mild to moderate
laudication. Because graft occlusions were well tolerated
y the patients due to arterial collaterals, no additional
rocedures were undertaken.
Apart from suture infection that occurred in 3 patients,
o major adverse event was seen in those patients that we
perated on.
Survival. By the end of follow-up, only 1 patient had
ied 6 months after being operated on, as we noted above.
nother patient was lost to follow-up after 1 month of the
urgery. We had the outcome information in the remaining
3 patients. All 23 patients (92%) were alive after a mean of
.4 2.9 years. By the end of follow-up, 12 patients (52%)
omplained of mild to moderate claudication. The majority
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January 2012160 Tuzun et al(16 of 23 patients; 70%) were in complete remission for
other stigmata of Behçet disease; whereas the remaining
patients had one or more Behçet disease symptoms. There
were only 6 patients with oral ulcers, 2 patients with papu-
lopustular lesions, 3 patients with arthralgia, 1 patient with
erythema nodosum, and another with stasis ulcer on the
tibia due to the chronic DVT. The only patient who had to
be interviewed over the telephone had attended our outpa-
tient clinic for the following postoperative year then was
followed by another institution. He reported that he had
no pain, no claudication, and no Behçet disease symptom.
Medical treatment. Corticosteroids were adminis-
tered as 3 pulses of 1 gram prednisolone (every other day)
and continued at a dose of 1 mg/kg/day for 1 month then
tapered by 10 to 20 mg/month but usually continued for
at least 1 to 2 years at a dose of 5 to 10 mg/day.
Three patients, including the 1 patient who was lost to
follow-up, received only corticosteroids.
A total of 20 patients received cyclophosphamide and 2
patients received azathioprine (AZA) in addition to corti-
costeroids, making 22 patients (88%) in total who were
treated with immunosuppressive agents. Cyclophosph-
amide (most commonly in the form of monthly 1 gram
intravenous boluses) was given for a duration of median 12
months (interquartile range, 12-14 months), then switched
to AZA for maintenance treatment. By the end of the
follow-up, 15 patients (60%) were still using an immuno-
Fig 1. a and b, A 37-year-old man, diagnosed with Beh
for flank and abdominal pain of 2 months’ duration. Co
aneurysms each with a diameter of 1 cm at the infraren
treatment with cyclophosphamide and corticosteroids.suppressive agent (AZA, n  13; mycophenolate, n  1; Vnterferon, n  1). Apart from 1 patient who had died and
patient lost to follow-up, 8 patients were drug free.
ISCUSSION
We report here the outcome and treatment results of
5 patients with Behçet disease with nonpulmonary artery
neurysms (23 patients) and occlusions (2 patients) fol-
owed in a single center.
The frequency of arterial aneurysms in Behçet disease is
eported to be rare.2,5 In a retrospective survey of 6000
atients with Behçet disease registered in the multidisci-
linary Behçet Syndrome Research Center at the Cerrah-
asa Medical Faculty, the frequency of aneurysm formation
including pulmonary artery aneurysms) was 2.5%.12 As has
reviously been reported, arterial aneurysms are mainly
een among men2-5 and the same was true with only 1
emale patient in the current series.
Major arterial involvement is known to be a late phe-
omenon developing 5 years after the fulfillment of the
iagnostic criteria.2-5,8,12 Similarly, in the current study,
he time elapsed between diagnosis of Behçet disease and
mergence of aneurysms was a mean 9.0  7.9 SD years.
nother distinguishing feature of the patients with arterial
nvolvement is accompanying severe eye problems and
enous thrombosis.5,13 These were also apparent in our
tudy. One third of the patients had lost useful vision in
oth eyes and 88% of the patients had venous thrombosis.
isease for 15 years, was admitted to the outpatient clinic
ed tomography (CT) angiogram showed three saccular
rta. The patient’s symptoms disappeared after medicalçet d
mput
al aoenous thrombosis is also known to be strongly associated
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Volume 55, Number 1 Tuzun et al 161with pulmonary artery disease.2,4,12,14 However, the asso-
ciation of peripheral artery disease with pulmonary artery
involvement seems rather weak12 and our observation of no
patients with pulmonary arterial aneurysms in this group
supports this contention.
In Behçet disease, active inflammation of the involved
artery destroys the elastic and muscle cells in the media with
aneurysmal dilatation. Occlusion of the vasa vasorum
speeds this process by transmural necrosis and later with
perforation and pseudo aneurysm formation.6,15 False an-
eurysms originate from defective areas in the aortic wall.
Sometimes there is more than one defective or weakened
area. We noticed that dimensions of the abdominal aortas
were within the normal range (data not given) with abun-
Fig 2. A 30-year-old man, diagnosed with Behçet disease for 3
years, was referred to our department for swelling and pain on both
sides of the neck. Magnetic resonance angiogram (MRA) showed
bilateral fusiform aneurysms (2 and 3 cm in diameter and 5 and 4
cm in length, for right and left side, respectively) at the carotid
arteries. The patient’s symptoms gradually disappeared after med-
ical treatment with cyclophosphamide and corticosteroids.dant inflammatory fibrotic tissue with or without enlarged 9ymph nodes around. These features contrast with what is
een in atherosclerotic aneurysms.
Although there are reports of patients who were treated
s an abdominal emergency because of free rupture,16,17
one of our patients with abdominal aorta and extremity
rtery pathologies were treated on an emergency basis. This
as similar in our previous report8 in which only 1 patient
ith a common carotid pseudo aneurysm had to have
mergency surgery because of airway compression.8 Behçet
isease has an undulating course of exacerbations and re-
apses. During each exacerbation, dense inflammatory tis-
ue builds up around the involved arteries. In all our
bdominal aortic cases, the aorta was found to be sur-
ounded by a thick fibrotic tissue. Presumably, this fibrotic
issue prevents the catastrophic intraperitoneal free rupture.
Another feature of Behçet disease is the arterial occlu-
ion. This distinctly less common pathology has a relatively
enign course. Since 1977, we have treated only 2 patients
ith Behçet disease with symptomatic occlusive pathology,
hich are reported in the current manuscript. One of them
ad digital gangrene, and another was a young patient who
ad transient ischemic attacks due to severe narrowing of
he carotid bifurcation. Femoral below-knee bypass with a
TFE graft had been inserted in the former and standard
arotid endarterectomy with a PTFE patch was undertaken
n the latter.
Aneurysm formation in Behçet disease is rather painful
ecause of its inflammatory nature. For this reason, periph-
ral aneurysms are easily detected by the patient himself/
erself. However, the detection of aneurysms confined to
he abdominal aorta needs a great degree of suspicion.
sually patients will complain of back pain, stubborn con-
tipation, and other symptoms due to venous thrombosis.8
lank pain will be the only symptom in iliac artery false
neurysms due to constriction of the ureter with dense
nflammatory tissue around the aneurysm. A CT scan will
ive important information about vascular morphology. It
s very important to refrain from conventional angiography
n that the arterial punctures have the propensity to cause a
athergy reaction and eventually cause localized arteritis
nd aneurysm.18,19 We use contrast-enhanced CT, MRA or
oppler scan during the preoperative and postoperative
eriod.
Most of the vascular surgery performed in Behçet dis-
ase is for aneurysms. The commonest localization of the
neurysms is the aortic bifurcation.8,9,16,17 Except for small
accular aneurysms without rupture, we resorted to surgery
n all others. During operation, proximal aortic control is
ecured below the left renal vein without difficulty. Now we
refer to use bifurcated (PTFE) grafts between the aorta
nd the proximal common iliac arteries. This method ex-
ludes the aortic bifurcation and no anastomotic dehis-
ence is encountered. While thick fibrotic tissue around the
orta makes suturing easy and safe, it prevents proper
solation of the synthetic grafts. For this reason aorto
raft-enteric fistula is a serious complication in patients
ith Behçet disease.20 In our first report,8 2 patients (2 of
) had died because of massive gastrointestinal bleeding
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January 2012162 Tuzun et aldue to aortoenteric fistula. We avoided this complication by
wrapping an omental flap around the grafts.8 We used this
technique in the five aortic aneurysms we operated on and
saw no gastrointestinal bleeding complication.
Synthetic patch closure of the defects has a high recur-
rence rate with suture dehiscence.9 This complication oc-
curred in 1 of our patients with a false aneurysm originating
from a defect on the anterior wall of the aorta between the
origins of celiac and mesenteric superior arteries. We had
repaired the defect with a PTFE patch, but he had a suture
dehiscence 6 months later. This patient died of exsangui-
nation while waiting for an endograft.
In Behçet disease, the diseased arteries are also quite
friable and we think that this feature might contribute to
the high recurrence rate when a bypass procedure is per-
formed. From our earlier experience, we had noticed that
graft occlusion was well tolerated in patients with Behçet
disease.8 This time, of 10 PTFE grafts inserted for extrem-
ity aneurysms, four grafts occluded in 1 year. Apart from
mild to moderate claudication, this complication was again
well tolerated, therefore, no further attempt is made for
occluded grafts. The same finding is reported by Kwon et
al.9 Also, Hosaka et al21 reported 35.7% graft occlusion
incidence in their patients. So, in our first report, we had
suggested ligature in the first instant.8 We had measured
the sump pressures and if they were over 50 mm Hg we
ligated the arteries.8 We were able to ligate two superficial
femoral, two popliteal, one posterior tibial arteries, and one
iliofemoral venous conduit without any severe disabling
ischemia in this series. We think that ongoing inflammation
in Behçet disease induces abundant new collaterals. It is
known that angiogenesis may develop as a compensatory
response to ischemia and inflammatory stimulus and that
Behçet disease is one of the few vasculitis that can cause
angiogenesis.22 Also, vascular endothelial growth factor
which is a potent stimulator of angiogenesis is reported to
be increased in Behçet disease.23
We recently had to ligate a common iliac artery for a
Fig 3. a, Histopathological image of popliteal artery
loss of elastic and muscle fibers in the media can be see
Van Gieson, 100). b, Also infiltration of inflamm
(hematoxylin and eosin stain, 200).recurrent saccular aneurysm 10 years after the last operation wf iliofemoral venous conduit ligation in a patient in this
eries. This patient complained of short-distance claudica-
ion probably because of ligation at two levels. All other
atients either with ligation or with occluded grafts expe-
ienced mild to moderate claudication. When the sump
ressure is low or back bleeding is poor, we inserted PTFE
rafts which are commonly used in our department. These
ays we never use vein grafts in Behçet disease. Because of
he high frequency of venous involvement in Behçet dis-
ase, veins immediately degenerate and develop false aneu-
ysms. In the current cohort, we ligated one iliofemoral
enous conduit because of the degeneration of the vein
raft inserted in another clinic.
With the introduction of endovascular grafts, reports
tarted to appear about treating Behçet disease aneurysms
ith endovascular techniques.9,24-27 Kwon et al9 reported
0% recurrence rate for stent graft insertion in the infrarenal
bdominal aorta. When the aneurysm is in the aortic bifur-
ation, which is the commonest site, there is a risk of new
neurysm formation in the proximal landing zone of the
raft just distal to the take-off of the renal arteries.9 Similar
omplication of proximal landing zone aneurysm has been
eported by Nakai et al.10 So with the endovascular treat-
ent, the pathology gets even more complicated. Also,
here is the risk of aneurysm formation at the femoral cut
own sites.18,19 Thus, none of our patients had a stent
nserted.
Interestingly, four saccular aneurysms at the abdominal
orta in 2 patients were followed-up by medical therapy
nly. In 1 patient, there were three saccular aneurysms at
he aorta (Fig 1). In another patient, two aneurysms were
etected at the aorta. One was a symptomatic large bifur-
ation aneurysm which was operated with a PTFE graft.
he other lesion was a saccular aneurysm of 1.5-cm diam-
ter which was conservatively managed by immunosup-
ressive therapy. This aneurysm partly occluded with
hrombus and decreased in size under immunosuppressive
reatment during a 5-year follow-up. Likewise, 2 patients
rysm. Loss of internal elastic membrane (arrow) and
ng with periadventitial and intimal thickening (Elastic
y cells around the vasa vasorum (arrow) is notedaneu
n alo
atorith carotid aneurysms were treated only by medical
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bifurcation and the other had bilateral common carotid
fusiform aneurysms (Fig 2). As we were planning an oper-
ation for the second patient, neck enlargement diminished
with induction immunosuppressive therapy and an MRA
showed reduction in the size of the fusiform aneurysm.
Hence, we decided to follow the patient under medical
therapy. During the follow-up period of 6 years, he had no
problems with his carotids but had stasis ulcers on the lower
extremities due to chronic DVT.
It is also worth noting here that the overall mortality
among our 24 patients operated on before 1997 for large
arterial disease was 17% at 4 years.8 Although strict com-
parisons between the previous and the cohort might be
subject to many biases, the fact that all the reported expe-
rience was from one center and the operating surgeon had
been the first author in either instance makes us rather
confident that we are doing better these days in managing
these vascular complications of Behçet disease.
In conclusion, the surgical management of large, non-
pulmonary, arterial diseases of Behçet disease is quite satis-
factory. When the false aneurysm is in the infrarenal aorta,
aorto-bi-iliac bypass is the preferred surgical intervention.
For false aneurysms located between the visceral arteries,
patching with synthetic material gives unfavorable results.
Extremity aneurysms can be treated with synthetic graft
insertion. In selected cases, ligation can give satisfactory
results; however, postoperative claudication is common. In
some patients with small intact saccular aneurysms, surgery
may not be necessary. Patients must be prescribed immu-
nosuppressive therapy with cyclophosphamide and cortico-
steroids before and after the surgical intervention in order
to avoid Behçet disease activation.
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